- Home
- Companies
- Impulse Dynamics
- News
- Impulse Dynamics Announces First ...
Impulse Dynamics Announces First Optimizer Implant in China
Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, today announced the first implantation of a patient in China with its innovative Optimizer system delivering CCM therapy. Cardiologist Dr. Hua Wei from the renowned Fuwai Hospital of the Chinese Academy of Medical Sciences performed the successful implant procedure.
Dr. Wei shared, “We are currently relying on medication only for the treatment of heart failure. If medication doesn’t work, then we don’t have a better solution. We now have a new option — CCM therapy — for these patients with a narrow QRS heart failure. For the vast majority of patients with heart failure, I think the implant performed today has a significant meaning for the future.”
The Optimizer, harnessing advanced engineering, delivers CCM therapy — the company’s proprietary technology — to the heart. CCM therapy has been pioneered by Impulse Dynamics to significantly improve heart contraction, allowing more oxygen-rich blood to be pushed throughout the body.[1] The Optimizer delivers precisely timed electrical pulses to the heart during the absolute refractory period of the beating cycle, immediately after the heart contracts. This breakthrough device improves the quality of life for heart failure patients no longer able to benefit from medication meant to manage symptoms and slow the progression of their condition.[1]
“Following years of collaboration between accomplished Chinese clinicians and our local team to obtain market authorization, we are happy to be offering the breakthrough technology of CCM therapy to Chinese patients and their families to restore their quality of life and help them regain hope,” said Simos Kedikoglou, CEO of Impulse Dynamics.
CCM® is the brand name for Cardiac Contractility Modulation, the non-excitatory electrical pulses delivered by the implantable Optimizer device to improve systolic contraction of the heart. The Optimizer Smart System was granted Breakthrough Device designation by the U.S. Food and Drug Administration, and it is the first and only CCM® device approved in the U.S. CCM® therapy sends unique electrical pulses to the heart cells during the absolute refractory period, which occurs just after the heart initiates contractions. In doing so, it strengthens and helps the heart contract more forcibly. Impulse Dynamics has completed numerous clinical studies, including several randomized controlled trials, the results of which have been published in over 80 articles appearing in leading medical journals. Studies have shown CCM® therapy to sustainably improve 6-minute hall walk distance, quality of life and functional status among patients who are candidates for the device. The Optimizer Smart has been implanted in over 4,000 patients and is currently available in the U.S., Europe, China, Brazil, India and more than 40 other countries around the world.
About Impulse Dynamics
Impulse Dynamics, based in Marlton, N.J., is dedicated to helping healthcare providers enhance the lives of people with heart failure by transforming how the condition is treated. The company has pioneered CCM® therapy, which is delivered by the company’s Optimizer® system, a breakthrough, FDA-approved treatment verified to improve the quality of life for heart failure patients. CCM therapy is a safe and effective minimally invasive treatment option for many heart failure patients who otherwise have few alternatives available to them. To learn more, visit www.ImpulseDynamics.com, or follow the company on social media at LinkedIn, Twitter, and Facebook.